Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients

Clinical trial NCT06885476 · RECRUITING

Trial details

NCT number: NCT06885476
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Minimal Residual Disease Natural Killer Cell

Start date: 2021-01-22
Primary completion: 2025-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.